{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-115089","form_type":"8-K","ticker":"CYCN","cik":"0001755237","company_name":"Cyclerion Therapeutics, Inc.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.594668+00:00","generated_at":"2026-05-22T08:36:42.300323+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cyclerion enters $20M ATM equity distribution agreement with Guggenheim","bullets":["Entered Sales Agreement with Guggenheim Securities for at-the-market offering of up to $20M of common stock.","Guggenheim will receive 3% commission on gross proceeds; sales limited by public float under Instruction I.B.6.","Company has not sold any securities under Instruction I.B.6 in prior 12 months; current public float below $75M.","Legal opinion from Ropes & Gray covers sale of up to $2,994,080 of Shares under the agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-115089","json":"https://secwatch.observer/filing/0001193125-25-115089.json","markdown":"https://secwatch.observer/filing/0001193125-25-115089.md","text":"https://secwatch.observer/filing/0001193125-25-115089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1755237/000119312525115089/0001193125-25-115089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1755237/000119312525115089/d51125d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T08:36:42.300323+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}